TCT-81 Quantification of Procedural and Anatomical Determinants of Multielectrode Renal Denervation

The failure of the prospective, randomized, sham-controlled SYMPLICITY HTN-3 trial to show significant difference in reduction of systolic blood pressure (SBP) in patients with resistant hypertension 6 months after renal denervation (RDN) compared with control subjects was attributed in part to